NCT03505307View on ClinicalTrials.gov

Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation)

CompletedOBSERVATIONAL
Enrollment

846

Participants

Timeline

Start Date

May 21, 2018

Primary Completion Date

December 7, 2020

Study Completion Date

December 7, 2020

Conditions
Ovarian Cancer
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT03505307 - Lynparza Ovarian Cancer Clinical Experience Investigation (All Case Investigation) | Biotech Hunter | Biotech Hunter